Monte Rosa Therapeutics Inc (GLUE) — Cash Flow Reinvestment Rate
Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting $38.79 Million (capex $651.00K plus investments $38.14 Million) from operating cash flow of $100.43 Million. Check Monte Rosa Therapeutics Inc (GLUE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Monte Rosa Therapeutics Inc Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Monte Rosa Therapeutics Inc across 1 annual periods. Explore GLUE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year capital reinvestment analysis for Monte Rosa Therapeutics Inc. For live market cap and broader valuation context, see Monte Rosa Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.15x | $48.44 Million | $42.00 Million | $3.99 Million | — |